Interventional Cardiology

Interventional Cardiology encompasses the diagnostic and non-surgical treatments of the heart through percutaneous coronary intervention (PCI). This involves the management of coronary artery occlusion by various catheter-based techniques, such as percutaneous transluminal coronary angioplasty, atherectomy, excimer laser angioplasty, and implantation of coronary stents and related devices.

Interventional Cardiology

Acute Myocardial Infarction (AMI)

  • Acute Myocardial Infarction (AMI)
  • Subjects who experience an acute myocardial infraction (AMI) are at substantial risk for recurrent infarction, angina, stroke, and sudden death. Early reperfusion is a well established factor in limiting myocardial damage. IABP therapy has been shown to improve outcomes in these patients. Click below to read more...
  • View Acute Myocardial Infarction (AMI)...

Cardiogenic Shock

  • Cardiogenic Shock
  • Cardiogenic shock remains a leading cause of death in AMI. The incidence occurs in about 5 - 8% of patients hospitalized with STEMI and has a mortality rate of about 50%.* IABP therapy has a class I recommendation in the treatment of patients in cardiogenic shock. Click below to read more...
  • View Cardiogenic Shock...

High-Risk PCI

  • High-Risk PCI
  • Patients with poor LV function undergoing high-risk PCI may develop hypotension and decreased cardiac output leading to hemodynamic instability. Accordingly, prophylactic stabilization with IABP therapy is often employed in these high-risk patients.** Click below to read more...
  • View High-Risk PCI...

BCIS-1: Balloon Pump-Assisted Coronary Intervention

  • Positive long-term mortality results from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1), which evaluated the effect on major complications and mortality of elective use of an intra-aortic balloon pump (IABP) in patients with low ejection fraction undergoing high-risk percutaneous coronary intervention (PCI).
  • View BCIS-1: Balloon Pump-Assisted Coronary Intervention...

* Cardiogenic shock current concepts and improving outcomes. H R Reynolds et al. Circulation 2008 ;117 :686-697

** A Prospective Feasibility Trial Investigating the Impella 2.5 System in Patients Undergoing High-Risk PCI. S R Dixon JACC 2009;2:91-6